throbber
BIOCHEMISTRY
`
`FIFTH EDITION
`
`New York
`
`Jeremy M. Berg
`Johns Hopkins University School of Medicine
`
`John L. Tymoczko
`Carleton ( -ollege
`
`Lubert Stryer
`Stanford University
`
`Web content by
`Neil D. Clarke
`{
`cT
`rt
`r
`f Medicine
`
`ne
`
`hns [Hf
`oy
`
`W. H. Freeman and Company
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`Page 1
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 1
`
`

`

`Page 2
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`
`
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 2
`
`

`

`Enzymes: Basic Concepts and Kinetics
`
`HO
`
`Oy, Ca
`Aeguaiein
`
`Ho
`
`Oo
`wm
`WW
`
`NH + CO, + GO 186 om)
`
`The activity of an enryme is responsible for the glow of the
`luminescent jellyfish at lett. The ennme sequenn catalynes the
`qaidaion of a
`compound by caygen in the pevence of calcu to
`thease CO are Her (fue) Feed Bavendaen Peter Arreoie|
`
`to Coenrymes
`
`Enzymes, the catalysts of biological systems, are remarkable molecular de
`vices that determune the patterns of chemical transformations. Theyalso
`mediate the transformation of one form of energy into another. The most
`striking characteristics of enzymes are ther catalytic power
`and specificity Catalysis takes place at a particular site on
`the enzymecalled the actrie site. Nearly all known enzymes
`are protems. However proteins do not have an absolute mo
`nopoly on catalysis;
`the discovery af catalytecally active
`RNA molecules provides compelling evidence that RNA
`‘was an early biocatalyst
`(Section
`2.2.2
`Proteins as a class of macromolecules are hechly effec
`:
`tive catalysts for an enormous diversity of chemical rea
`tions because of their
`capacity te specifically bind a wery unde
`range af molecules,
`By utilizing the full repertoire
`of inter
`molecular forces, enzymes bring substrates together im an
`optimal orientation,
`the prelude to making and breaking
`chemical bonds. They
`catalyze reactions by stabilizing tran
`Htion states,
`the highest-cnergy
`species
`reaction path
`ways. By selectively stabilizing a transition state, an enzyme
`|
`determines which one of
`several potential
`chemucal rea
`Hons actually takes
`pla
`—— ,
`——
`
`> 8.1 Enzymes Are Powerful and Highly
`Specific Catalysts
`? 6.2 Free Energy ts a Useful
`The
`mac Function
`for Understanding Enrymes
`* 6.3 Enzymes Accelerate Reactions
`by Facilitating the Formation of the
`Transition State
`* 6.4 The Michaelis-Menten Model
`Accounts for the Kinetic Properties
`of Many Enrymes
`6.5 Enrymes Can Be Inhibited
`by Specific Molecules
`6.6 Vitamins Are Often Precursors
`
`
`IPR2021-01507
`
`Page 3
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 3
`
`

`

`
`
`Page 4
`
`
`uspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 4
`
`

`

`Page 5
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 5
`
`

`

`ATP + NMP == ADP + NDP
`
`8.1.3 Enzymes Are Classified on the Basis
`of the Types of Reactions That They Catalyze
`eer Ceopatnouaa ee Many enzymes have common names that provide little
`aiuiael dahabaiiba a Cit” ered
`information about
`the reactions that they catalyze. For
`example, a proteolytic enzyme secreted by the pancreas
`mec alled trypan Mira other enzymes are famed low their substrates and
`for the reactions that they catalyze, with the suffix “ase” added. Thus, an
`ATPase is an enzyme that breaks down ATP, whereas ATP synthase ia
`an enzyme that ayntheazes ATP.
`in 1964
`lo bring some consistency to the classification of enzymes,
`the International Union of Biochemistry established an Enzyme Commis-
`sion to develop a nomenclature for enzymes. Reactions were divided inta
`ax major groups numbered 1 through 6 (Table 5.3). These groups were
`subdivided and further subdivided, so that a four-digit number preceded
`by the letters
`EC
`for Enzyme Commission could precisely identify all
`enzyme
`
`as an example nucheoside monophosphate (NMP) kinase, an
`(Consider
`nme (hat we will Canine in detail in the nest chapter (Section 94)
`lt
`italyzes the following reaction
`
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`Page 6
`
`(192)
`CHAPTER @ + Enzymes: Basic Concepts and
`hinatet
`
`Cofactors that are small organic molecules are called coenzymes, Often
`derived from vitamins, coenzymes can be either tightly or loosely bound to
`the enzyme, Lf tightly bound, they are called prosthetic groups. Loosely as-
`sociated coenzymes are more like cosubstrates because they bind to and are
`released from the enzyme just as substrates and products are. The use of the
`same coenzyme by a variety of enzymes and their source in vitamins sets
`coenzymes apart from normal substrates, however. Enzymes that use the
`same coenzyme are usually mechanistically similar. In Chapter 9, we will
`examine the mechanistic importanceofcofactors to enzyme activity. A more
`detailed discussion of coenzyme vitamins can be found in Section 4,6,
`
`8.1.2 Enzymes May Transform Energy
`from One Form into Another
`
`In many biochemical reactions, the energy of the wactants
`wconverted with high efficiency into a different form. For ex-
`ample,
`in photosynthesis, light energy is converted into
`chemical-bond energy through an ion gradient. In mito:
`chondria, the free energy contained in amall molecules de-
`rived from food is converted first into the free energy ofan
`ion gradient and then into a different currency,the free en-
`ergy of adenosine triphosphate. Enzymes may then use the
`chemical-bond energy of ATP in many ways. The enzyme
`myosin converts the energy of ATP into the mechanical en-
`ergy of contracting muscles. Pumps in the membranes of
`cells and organelles, which can be thought of as enzymes
`that move substrates rather than chemically altering them,
`create chemical and electrical gradients by using the energy
`of ATPto transport molecules and ions (Figure 8.2), The
`molecular mechanisms of these energy-transducing en-
`#ymes are being unraveled. We will see in subsequent chap:
`ters how unidirectional cycles of discrete stepa—binding,
`chemical transformation, and release—lead to the conver-
`sion of one form of energy into another
`
`
`
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 6
`
`

`

`Page 7
`
`
`uspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 7
`
`

`

`Page 8
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`
`
`
`
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 8
`
`

`

`TABLE 6.4 Relation between AG"
`and €,,,
`(at 75°C)
`is
`
`Aci
`kealmol”'
`
`kJ/mol
`
`The equilibrium constant under standard conditions, K’,.,, 1 defimed as
`clip
`4/6
`
`k
`
`i
`
`Substituting equation 4 into equation 3 gives
`AG
`RT Ink
`;
`
`AG
`
`1 303RT log,,,K’
`
`which can be rearranged to give
`
`K.
`
`Substituting R = 1.987 *
`sponding to 25°C) gives
`
`10
`
`deg”
`
`' and T
`
`= 298 K (corre
`
`K
`
`sa-8
`
`’
`
`in
`
`6G°" =
`
`—2.303RT log,
`
`ms = Ley x
`
`10
`

`
`J98 =
`
`how (0.04075
`
`= +1.80 kcal mol
`
`“(7.53 k] mol
`
`the reaction is endergonc, DHAP will not spon
`Under these conditions,
`tancously convert to GAP
`Sow let us-calculate AG; for this reaction when. the initial concentration
`of DHAP w 2?
`=
`10
`M and the
`initial concentration of GAP ws
`3
`107° M. Substituting these values into equation | gives
`
`WART low
`
`x 10°°M
`~«
`10° M
`
`coupling of react
`
`where AG*" is here expressed in kilocalories per mole because of the choice
`of the units for R in equation 7. Thus, the standard free energy and the equi
`librium constant of a reaction are related by a simple expression. For ex-
`ample, an equilibrium constant of 10 gives a standard free-energy change
`of —1.36 keal mol
`(—5.69 kJ mol”
`') at 25°C (Table 8.4). Note that, for
`each 10-fold change in the equilibrium constant,
`the AG*’
`changes by
`1.46 keal mol~*(5.69 k] mol
`As an example,
`let us calculate AG°* and AG for the isomenzation of
`dikydroxyacetone phosphate
`(DOHAP)
`to glyceraldehyde 3-phosphate
`(GAP). This reaction takes place in glycolysis (Sectoon 16.1.4). At equilibrium
`the ratio of GAP to DHAP is 0.0475 at 25°C (298 K) and pH 7, Hence
`Keg = 0.0475, The standard free-energy change for this reaction is then
`calculated from equation |
`
`An
`
`Lo
`
`+ that
`
`the tsomerizat
`1rd
`the
`This negative value for
`qusly when
`the
`apor
`ur
`can
`fo GAP is exergonic
`and
`ncentrations. Note that 4tr for
`this re
`Present at the alorestated
`sitive.
`if
`mportant
`to
`str
`fegative, although Ati
`AG: for a reactionwlary
`i
`Centrale: of
`the
`reactant
`ha prac [he
`crote
`reaction is ACs,
`not
`hot spontancous
`|
`concentrations ot
`
`1
`
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 9
`
`

`

`
`
`The equilibrium constant under standard conditions, K’,.,, 1 defined as
`
`cip
`
`AG)
`Substituting equation 4 into equation 3 gives kealmol™'=kJ/mol!
`
`4AG*
`= —RTIinK’,,
`
`4/B
`
`TABLE 6.4 Relation between iG*
`and K,,, (at 25°C)
`-—————_
`
`Coupling of reactions t
`
`the reaction is endergonic. DHAP will not spon
`Under these conditions,
`tancously convert to GAP
`Now let us calculate AG for this reaction when the initial concentration
`of DHAP is 2 * 10°° M and the
`initial concentration of GAP ww
`3
`10-7" M Substituting these values into equation | gives
`"h
`7x 10°
`
`
`~ 2 LO M
`
`AG
`
`, WART log, K'
`
`which can be rearranged to give
`
`K ‘
`
`TT
`
`4
`
`Substituting R= 1.987 *
`sponding to 25°(") gives
`
`10°*
`
`keal mol”'
`
`deg”! and T = 298 K (corre
`
`kK"
`
`17% “
`
`(fk
`
`where AGs*" is here expressed in kilocalorves per mole because af the chrwce
`ofthe wnits for R in equation 7. Thus, the standardfree energy andthe equi
`;
`I
`P
`librium Constant of a reactron are related by a simple expression. For ex-
`ample, an equilibrium constant of 10 gives a standard free-energy change
`of —1.36 keal mol
` (—3.69 k] mol‘) at 25°C (Table 8.4). Note that, for
`q
`ges
`by
`:
`each 10-fold change in the equilibrium constant, the AG*’ changes by
`1.36 keal mol™' (5.69 kJ mal
`As an example,
`let us calculate AG** and AG for the isomerization of
`dihydroxyacetone phosphate (DHAP)
`to glyceraldehyde 4-phosphate
`(GAP). This reaction takes place in glycolysis (Section 16.1.4), At equilibrium
`the ratio of GAP to DHAP is 0.0475 at 25°C (298 K) and pH 7. Hence
`cr]
`Kg = 0.0475. The standard free-energy change for this reaction is then
`calculated from equation 6
`
`4G*" =
`
`-J ART low A
`
`| OR?
`2.503 *
`= +1.480 kcal mol
`

`
`x 08 &
`10
`'(7.53 kJ mol‘)
`
`long
`
`(0.0475
`
`AG=1.80 keal mol + 2.303RT log
`
`= 1.80 kcal mol
`
`49 keal mol
`
`69 bocal mod
`
`2.89 k] mol
`
`the isomerization of DHAP
`‘This negative value for the AG indicates that
`to GAPis exergor
`nd Cn GCCur spontaneously when. these SCs af
`present at the aforestated
`concen
`Note that At; for this rea
`fegative, although Ad:
`is
`AG for a faction i
`lorger
`centration: of the reacta
`reaction is AG:, not Ads
`not spontancous based o
`Concentrations of
`read
`
`l
`
`
`
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 10
`
`

`

`196
`CHAPTER & + Enzymes: Basic Concepts and
`Kinehecs
`
`8.2.3 Enzymes Alter Only the Reaction Rate and Not the
`Reaction Equilibrium
`
`Hecause enzymes are such superb catalysts, it 15 tempting to ascribe to them
`powers that they do not have, An enzyme cannot alter the laws of thermo
`dynamics and conseyguently cannot alter the equilibrium of a chemical reac
`tion. This inability means that an enzyme accelerates the forward and re-
`verse reactions by precisely the samefactor Consider the interconversion
`of A and B. Suppose that, in the absence of enzyme, the forward rate con-
`stant (kp) is 10°* s~'
`and the reverse rate constant (ky) is 10°" s_'. The
`equilibrium constant Kis given by the ratio of these rate constants
`
`K =
`
`A,
`
`Ry
`
`nm 100
`
`The equilibrium concentration of Bis 100 times that of A, whether or not
`enzymeis present. However, it might take considerable time to approach
`this equilibrium without enzyme, whereas equilibrium would be attained
`rapidly in the presence of a suitable enzyme. Enzymes accelerate the attain-
`ment of equilibria but do not shift their positions. The equilibrium position is
`a function only of the free-energy difference betuwen reactants and products.
`
`8.3 ENZYMES ACCELERATE REACTIONS BY FACILITATING
`THE FORMATION OF THE TRANSITION STATE
`
`and vis the
`
`The free-energy difference between reactants and products accounts for the
`equilibrium of the reactoon, but enzymes accelerate how quickly this equi-
`librium is attained, How can we explain the rate enhancement in terms of
`thermodynamics? To do so, we have to consider not the end points of the
`reaction but the chemical pathway between the end points
`\ chemical reaction of substrate 5 to form product P goes through a
`transtiion state 5°
`that has a higher free energy than does either 5 or FP. The
`double dagger denotes a thermodynamic property of the transition state,
`| he
`transition state is the mast ee lcd Mk Cot cupied specws along the reaction
`pathway because it is the one with the highest free energy. The difference
`in free energy between the transition state and the substrate is called the
`Cobbs free energy of activation or simply the activation energy, symbolized
`by AG,
`as mentioned in Section §.2.1 (Figure 8.3)
`
`Transiteen state, 5
`
`FIGURE 6.5 Enrym
`activation energy
`react
`energy
`
`air
`
`Ls
`
`tay
`
`does not enter into the final 4G
`> that the energy of activation, or ACr*,
`i for the reaction, because the energy input required to reach the
`returned when the transition etate forme the product The
`barrier immediately suggests how enzymes enharice re
`yout altering AG of
`the reaction: enzymes function to lower
`ergy,
`or,
`in other words, enzwmes facilitate the formation of
`
`lerstanding how enzymes achveve this facilitateon is
`ri
`staae
`und the substrate
`(5) are in equilibrium
`
`formation of S*,
`
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 11
`
`

`

`Page 12
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`
`
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 12
`
`

`

`ontnbuted by
`
`1. The spectroscopic characteristics of many enzymes and substrates change
`on formation of an ES complex. These changes are particularly striking if
`the enzymecontains a colored prosthetic group. Tryptophan synthetase, a
`bacterial enzyme that contains a pyridoxal phosphate (PLP) prosthetic
`group, provides a nece illustration. This enzymecatalyzes the synthesis of
`L-tryptophan from L-serimne and incole-derivative. The addition of L-serine
`to the enzyme produces a marked increase in the fluorescence of the PLP
`group ( Figure §.6), The subsequent addition of indole, the second substrate,
`quen hes this Muorescence to a level even lower than that of the enzyme
`alone, Thus, Muorescence spectroscopy reveala the existence of an en-
`zyme-serine complex and of an enzyme-serine-indole complex. Other
`spectroscopic techniques, auch as nuclear magnetic resonance and electron
`spin resonance, also are highly informative about ES interactions
`
`}H cure 6.5 Strocture of an enryme-substrate complet. (Let) The enyme
`cytectiorme PSO i illustrated bound to its subsinate camphor
`(Right) im the active site,
`the substrate no wurounded by metidues from the ery Note alvo the presence of a
`here colactor
`
`Serine
`
`reactions. A new technique, time-resolwed crystallography, depends an co-
`erystallizing a photolabile substrate analog with the enzyme. The substrate
`analog can be converted to substrate light and images of the enzyme-
`substrate complex are obtained in a fraction of a second by scanning the
`ervetal with intense poly hromatic x-rays from a synchrotron
`
`8.3.2 The Active Sites of Enzymes Have Some Common Features
`Phe active site
`of an enzyme
`ia the region that binds the substrates (and the
`7,
`ifany).
`It also contains the residues that directly participate in the
`making and breaking of bonds. These rescues are called the catalytic groups
`e¢,
`the mteractiom of the enevew and substrate at the achiia ote pre
`formation of
`the
`transition state.
`The active site is the region of the
`hat moewt
`dir
`owers
`the AGr’
`of the reaction, which results in
`fenzyme action. Although enzymes
`ind mode of catalysis,
`a number al
`sites can be stated
`
`dil cleft formed by ae Lies that Come
`1 aeqquence
`deed,
`residues far apart
`ly
`than adwcent residues in the
`that che graces thé cell he alls
`
`
`
`Engyme alone
`Sr irbe
`and indole
`
`00
`
`Wavelength (rum)
`
`'t:t¢
`
`FIGURE 6.6 Change in spectroscopic
`characteristics with the formation
`of an enryme-substrate comples
`Phares
`me
`nteraty
`of
`th rns
`phaaphain g
`iyplophen
`
`a
`a Tyr #6
`hi
`
`@Sod val 2471
`—s
`Leu 24a
`Camphor (substan)
`
`CHAPTER 0 « Enryren Basic Concept and
`Kinetics
`
`a we
`Phe 87 »
`-
`
`Asp 297
`
`i.
`
`a


`

`i
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 13
`
`

`

`Page 14
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`
`
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 14
`
`

`

`5. The specificity of binding depends on the precisely defined arrangement of
`atoms in an activ site. Because the enzyme and the substrate interact by
`means of short-range forces that require close contact, a substrate must have
`a matching shape tofit into the site. Emil Fischer's analogy of the lock and
`key (Figure 8.9), expressed in 1890, has proved to be highly stimulating and
`fruitful. However, we now knowthat enzymes are flexible and that the
`shapes of the active sites can be markedly modified by the binding of sub-
`strate, as was postulated by Daniel E. Koshland,Jr., in 1958. The active site
`of some enzymes assume a shape that is complementaryto that of the tran-
`sition state only after the substrate is bound. ‘This process ofdynamic recog-
`nition is called induced fit (Figure 8.10)
`
`concentrations, Before we can accurately interpret
`
`Substrate
`
`+
`
`——"
`
`Enzyme
`
`in thes model, the
`FIGURE 6.10 Induced-fit model of enryme-substrate binding.
`enzyme changes shape on substrate binding. The actwe ste forms a shape complementary
`to
`the substrate only after the substrate has been bound
`
`6.4 THE MICHAELIS-MENTEN MODEL ACCOUNTS
`FOR THE KINETIC PROPERTIES OF MANY ENZYMES
`
`mary function of enzymes 16 to enhance rates of reactions so that
`compatible with the needs ofthe organism. To understand how en-
`are
`they
`1,
`we need a kinetic description oftheir activity. For many en-
`Eyres: fut
`f catalyais V5. which 1s defined as the number of moles of
`zymes, ‘th
`per second, varies with the substrate concentration [5] ma
`product formed
`manner shown in Figure 8.11. The rate of catalysis rises linearly as substrate
`1oenbration imecrea
`incl then begins to level off and approach a maxi-
`mum
`at higher substrate
`
`
`
`Apotex v. Auspex
`IPR2021-01507
`
`Page 15
`
`i
`
`200
`CHAPTER 8 + Enzymes: Basic Concepts and
`Kinetics
`
`FIGURE 6.9 Lock-and-key model of
`enryme-substrate binding.
`inthis
`model, the active site of the unbound
`enpyme is complementary in shape to
`the substrate.
`
`Enzyme
`
`
`
`
`
`Reactionvelocity(¥,,)—
`
`Substvate comcentration [5
`
`FIGURE 6.11 Michaelit-Menten kinetics
`A plot of the
`reat
`‘
`f
`i
`are tthe
`or a“
`cia aA
`(Ven) is
`approached asym
`Michaelis
`constant
`(x
`concentration yietcing
`
`i
`
`‘
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 15
`
`

`

`
`
`Page 16
`
`
`uspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 16
`
`

`

`
`
`CHAPTER 4+ Engynes: Basic Come epts and
`Kinetics
`
`is that the catalytic rate is equal to the product of
`starting point
`entration of the ES complex and ka
`
`the con
`
`\
`
`4,
`
`|ES
`
`10
`
`Now we need to express [ES] in tertns of known quantities. The rates of for-
`mation and breakdown of ES are given by
`
`Rate of formation of ES=kh, E
`
`Rate of breakdown of ES =
`
`(k_,
`
`+ k.)/ES
`
`In a
`To simplify matters, we will work under the steady-state assumption.
`steady state,
`the concentrations of intermeciiates,
`in this case [ES], stay the
`ame even if
`the concentrations of starting materials and products are
`changing, This occurs when the rates of formation and breakdown ofthe
`ES complex are equal. Setting the right-hand sides of equations 11 and 12
`equal RIVES
`
`h
`
`By rearranging equation 14, we obtain
`
`EIS//ES
`
`ty
`
`fk
`
`(13)
`
`(14)
`
`Equation 14 can be simplified by defining a new constant, Ky), called the
`Michaelis constant
`
`Kyi
`
`:
`k
`
`(15)
`
`Nate that Ky i has the units of concentration kK if 1S an Important charac-
`teristic of enzyme-substrate interactions and is independent of enzyme and
`substrate concentrations
`
`Inserting equation 15 into equation 14 and solving for [ES] yields
`
`(16)
`
`of equation 16. The concentrationof
`Now let us examine the numerator
`in ri br cl substrate || Very nearly equal
`to the
`total substrate con
`centration, provided that
`the concentration of enzyme is much lower than
`that of substrate. The concentration of uncombined enzyme
`[E) is equal
`to the total
`enzyme concentration | E|-- manus the concentration af the ES
`
`i camps x
`
`
`
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`Page 17
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 17
`
`

`

`Page 18
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 18
`
`

`

`
`
`CHAPTER 4 = Enzymes: Basic Concepts and
`Kinehes
`
`TABLE 6.5 Ay Values of some enzymes
`
`Enzyme
`
`Substrate
`
`Chymotrypsin
`Lysozyme
`A- Galactosidase
`The mine deaminase
`Carbonee anhydrass
`
`Penicillinase
`Pyruvate carboxylase
`
`Arginine-tR NWA synthetase
`
`tryptophanamuice
`«1
`Acetyl
`Hexa-N-acetylg¢]ucosamine
`Lactose
`Threonine
`CO
`
`Benzylpeniillin
`Pyruvate
`HCO,
`ATP
`
`Arginine
`tRNA
`ATP
`
`S000)
`hy
`4000
`S00)
`A000)
`
`50)
`400)
`joo0
`460)
`
`4
`
`fo
`
`V cx
`
`enzyme i the concentration ofactive sites
`
`equal to the dissociation constant of the ES complex if
`When this condition is met, Ky) is a measure
`omplex:
`a high Ky,
`indicates weak binding; alow
`iding.
`It must be stressed that Ky; indicates the affin-
`hen k_,
`1s much greater than ky
`veals
`the turnover number
`ol an enzyme, ” hich
`ules
`converted inte product by an enzyme mole-
`zyme
`is
`fully saturated with substrate.
`[t is equal
`
`hisalso called &.,,. The maximal rate, Vax
`fan
`
`with the use of « urve-litting Programs on a computer (See the appendix to
`this chapter for alternative means of determining Ky, and V,,,..). The Kay
`values of enzymes range widely (Table 8.5). For most enzymes, Ay, lies be-
`tween 107! and 107°
`M. The Kyy value for an enzyme depends on the pat-
`ticular substrate and on environmental conditions such as pH, temperature,
`and bons strength The Michaelis constant, Kat has Tan meanings First,
`Kyq 18 the concentration of substrate at which half the active sites are filled
`Thus, Ay provides a measure of the substrate concentration required for
`significant catalysis to occur.
`In fact, for many enzymes, experimental evi-
`dence suggests that Ky, provides an approximation of substrate concentra-
`tion in vive. When the Ku is known,
`the fraction of sites filled, fe 3, at any
`substr ale concentration can be 3 alculated fr om
`f
`fo
`oo
`Si + Kay
`
`(24)
`
`Second, Ky; is related to the rate constants of the individualsteps in the
`catalytic ac henne given in equation 9.
`In equation 15 Kay 15 defined as
`(hk
`+
`ky ky. Consider a limiting case in which k_
`|, is much greater than
`Bs, Under such circumstances, the ES complex dissociates to E and 5 much
`more rapidly than product is formed, Under these conditions (k_, >> bo),
`
`The dissociation constant of the ES ¢ omplex Is given DY
`
`(25)
`
`26)
`
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 19
`
`

`

`
`
`Page 20
`
` xhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 20
`
`

`

`
`
`206 |
`
`CHAPTER 8 + Enzymes: Basic Concepts and
`Kinetics
`
`values for several different substrates of chymotrypsin (Section 9.1.1). Chy
`motrypsin clearly has a preference for cleaving next to bulky, hydrophobic
`side chains
`How efficient can an enzyme be? We can approach this question by de-
`termining whether there are any physical limits on the value of &.,./ Kay.
`Note that this ratio depends on k,, k_,, and k;, as can be shown bysubsti-
`tuting for Ky,
`
`hea
`Fan
`
`kh, <
`Row
`Fea
`ig ae Okee
`
`(30
`
`)
`
`The whlizahon of attractive forces to
`lure a substrate into a site in which
`
`it undergoes a transformation of
`structure, at defied by Wilkam P
`Jencks, an enzymologist, who coined
`the term
`
`A goddess of Greek mythology, Circe
`lured Cehysseus's men to her house
`and then tunsionmed them into pigs
`
`PLLC anhwdrase
`
`Suppose that the rate of formation of product (hk...) is much faster than the
`rate of dissociation of the ES complex (k_,). The value of k../Kyq then
`approaches &). Thus, the ultimate limit on the value of k../ Kay is set
`by &,, the rate of formation of the ES complex. This rate cannot be faster
`than the diffusion -contralled encounter af an enzyme and tts substrate Duffu-
`sion limits the value of ky &O) that it cannot he higher than between id? and
`10° s°' M~'. Hence, the upper limit on k,,,/Ky,
`is between 10° and
`10° a
`'M
`ratios of the enzymes superoxide dismutase, acetyl-
`The Ri Ky,
`cholinesterase, and triosephosphate isomerase are between 10° and 10" '
`Mo! Enzymes such as these that have k.,,/A), ratios at the upper limits
`have attained kinetic perfection, Their catalytic velocity is restricted only by
`the rate at which they encounter substrate in the solution (Table 8.8), Anyfur-
`ther gain in catalytic rate can come only by decreasing the time for diffu-
`sion. Rernember that the active site is only a small part of the total enzyme
`structure. Yet, for catalytically perfect enzymes, every encounter between
`enzyme and substrate is productive.
`In these cases, there may be attractive
`electrostatic forces on the enzymethatentice the substrate to the activesite.
`Chese forces are sometimes referred to poetically as Circe effects.
`The limit imposed by therate of diffusion in solution can also be partly
`overcome by confining substrates and products in thelimited volume of a
`multienzyme complex. Indeed, some series of enzymes are associated into
`organized assemblies (Section 17.1.9) so that the product of one enzyme is
`very rapidly found bythe next enzyme.
`In effect, products are channeled
`from one enzyme to the next, much as in an assembly line.
`
`TABLE 8.8 Enzymes for which k,,./Ky is close to the diffusion-controfied
`rate of encounter
`
`Enzyme
`Acetyicholinesteraze
`
`(a ks
`
`Bear! Kya (5 "MO
`
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 21
`
`

`

`
`
`Page 22
`
`
`uspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 22
`
`

`

`Page 23
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`
`
`
`
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 23
`
`

`

`8.5 ENZYMES CAN BE INHIBITED
`BY SPECIFIC MOLECULES
`
`209
`
`Enaymne bnhebiion
`
`Subvirate
`
`The activity of many enzymes can be inhibited by the binding of specific
`small molecules and ions: This means of inhibiting enzymeactivity serves
`a8 a Major control mechanism in biological systems. The regulation of al
`hostenc enzymes typifies this type of control.
`In addition, many drugs and
`toxic agents act by inhibiting enzymes.
`Inhibition by particular chemicals
`can be a source of inghit inte the mechaniam of enzvme action specitic in-
`hibitors can often be used to identify residues critical for catalysis. The value
`of transition-state analogs as potent inhibitors will be discussed shortly
`Enzyme inhibition can bee either re versible of iffewv eruble An Fret ersible
`inhibitor dissociates very slowly from its target enzyme because it has be
`come tightly bound to the enzyme, esther covalently or noncovalently. Some
`imreversible inhibitors are important drugs. Penicillin acts by covalently
`modifying the enzyme transpepticlase, thereby preventing the synthesis of
`bacterial cell walls and thus killing the bacteria (Section 8.5.5 Aspirin acts
`by covalently modifying the enzyme cyclooxygenase, reducing the syn
`thesis of inflammatory signals
`Reversible mhibition,
`in contrast with irreversible inhibition, is charac-
`tenzed by a rapid dissociation of the enzyme—inhibitor complex.
`In com
`1
`tnfabition, ar enzyme can bind substrate (forming an ES complex)
`or inhibiter (EI) but not both (EST). The competitive inhibitor resembles
`the substrate and binds to the active site of the enzyme(Figure 8.15). The
`substrate ia thereby prevented from binding to the same active site, A com
`petitive inhibitor diminishes the rate of catalysis by reducing the proportion of
`enzyme molecules bound to w substrate. At any given inhibitor concentration,
`Competitive inhibition can be reliewed by increasing the substrate concen
`tration. Under these conditions, the substrate “outcompetes” the inhibitor
`for the active site. Methotrexate is a structural analog oftetrahydrofolate,
`a coenzyme for the enzyme dihydrofolate reductase, which plays a rolein
`the biosynthesis ot purines and pyrimidines (Figure 8.16). Tt binds to di-
`hydrofolate reductase 1000-fold more tightly than the natural substrate and
`inhibits nucleotide base aynthesis.
`It is used to treat cancer
`
`Irom bundling
`
`moeliti
`ipeetit
`(lap) enryrne— substrate
`inhibitor,
`(meddle) a cortpetitieve mbsbrtor
`complies,
`bers at the actwe site and thus prevents
`the substrate fram binding:
`(bottam) a
`Toroerpetitre nhbetor coe,
`re
`t prevent
`f
`the gubbstrate
`
`HM
`
`Tetvabydrotodate
`
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 24
`
`

`

`
`
`Page 25
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 25
`
`

`

`
`
`Page 26
`
`
`uspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 26
`
`

`

`
`
`Page 27
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 27
`
`

`

`
`
`Page 28
`
` hibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 28
`
`

`

`
`
`Page 29
`
` bit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 29
`
`

`

`
`
`Page 30
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 30
`
`

`

`Why ts penicillin such an effective inhibitor of the transpeptidase? The
`highly strained,
`four-membered f-lactam ring of penicillin makes it
`especially reactive, On binding to the transpeptidase, the serine residue at
`the active site attacks the carbonyl carbon atom of the lactam ring to form
`the penicilloyl-serine derivative (Figure 4.31). Because the peptidase par-
`hicipates in ite own mactivation, penicillin acts as a suicide inhibitor
`
`‘il ear in il hi mW int fegra a
`
`Coenzyme
`
`lypical reaction type
`
`Consequences of deficiency
`
`Thiamine pyrophosphate
`
`Aldehyde transfer
`
`Flavin adenine
`hinucleotide (FADD)
`
`Pyridoxal ph epihats
`
`Ohedahianreductian
`
`(aroup trainster to.or from
`immuno acids
`( hidation reduction
`
`group transfer
`ATT dependent
`arbosxylateen and
`l-froup transter
`1
`one carbon
`nite:
`thymine
`
`Beribers (weight loss,
`heart problema,
`neurological
`dyatunction |
`(Cheleosis and angular
`stomatitus (leaons of the
`mouth), dermatitis
`
`Depresnion, corbin
`convulsions
`Pellagra (dermaritis
`lepreasion,
`diarrhea)
`Hypertension
`Rash about the
`eyebrows, muscle pan
`fatigue (rare
`Anomia, nctinal- tube
`lefects in development
`
`Ancmia, Pernecivus
`inca, Methylene
`
`(ewollen ane
`Scurvy
`bles Lng Gums
`
`
`
`216)
`CHAPTER 8+ Entymes; Bast Concepts and
`Kinetecs
`
`FIGURE 8.31 Formation of a
`penicilloyl-enzyme compiles. Penicifin
`heacts with the transpeptidaw to form
`an inachve comptes, whech is
`indelnetety
`Mable
`
`Glycopeptide
`Iransreplidane
`
`Punicilloyl-oncyes comple
`(enrymatcally inacteen )
`
`8.6 VITAMINS ARE OFTEN PRECURSORS TO COENZYMES
`
`me Earlier (Section 8.1.1), we considered thefact that many enzymes re
`"quire cofactors to be catalytically active. One class ofthese cofactors,
`ter med COCnFYMes, OOnssts of smal] Ofganit molecules, mary of which ane
`derived from vitamins. Vitamins themselves are organic molecules that are
`needed in small amounts in the diets of some higher animals. These mole+
`
`-—
`TABLE 6.9 Water-Soluble Vitamins
`a
`
`Vitamin
`
`Thiamine (i
`
`
`
`
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 31
`
`

`

`Page 32
`
` 2014
`Apotex v. Auspex
`IPR2021-01507
`
`Auspex Exhibit 2014
`Apotex v. Auspex
`IPR2021-01507
`Page 32
`
`

`

`
`
`Proly! inpdroaplase
`+ moobete
`
`OH
`a-Hydiroxyproly!
`reudue
`
`Proline ns hydroxylated at C-4 by the
`FIGURE 0.55 Formation of 4-hydronyproline.
`acton of profyl hydrorylase. an enzyme that actwates molecular oxygen
`
`tic pe ly peptides have been
`
`still required for the continued activity of proyl hydroxylase. This enzyme
`synthesizes 4-hydroxyproline, an amino acid that ts required in collagen,
`the major connective tissue in vertebrates, but is rarely found anywhere else.
`How is this unusual amino acid formed and what ts its role? The results of
`radioactive-labeling studies showedthat proline residues on the amino aide
`of glycine residues in nascent collagen chains become hydroxylated. The
`oxygen atom that becomes attached to C-4 of proline comes from

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket